| | |
HBsAg+
|
Anti-HCV+
|
Double Positive
|
|---|
|
Variable
|
N (Percent)
|
N
|
P
|
N
|
P
|
N
|
P
|
|---|
|
Total
|
391(100%)
|
57(14.5%)
| |
282 (72%)
| |
31 (7.9%)
| |
|---|
|
Sex
| | |
<0.001
| |
<0.001
| |
<0.001
|
|
Male
|
358 (91.6%)
|
40(11.2%)
| |
274(76.5%)
| |
24 (6.7%)
| |
|
Female
|
33 (8.4%)
|
17(51.5%)
| |
8 (24.3%)
| |
7 (21.2%)
| |
|
Age
| | |
0.013
| |
<0.001
| |
<0.001
|
|
≤ 30
|
140 (35.8%)
|
18(12.9%)
| |
108 (77.2%)
| |
8 (5.7%)
| |
|
31-50
|
204 (52.1%)
|
27(13.2%)
| |
151 (74%)
| |
18 (8.9%)
| |
|
≥ 50
|
47 (12%)
|
12(25.5%)
| |
23 (48.9%)
| |
5 (10.6%)
| |
|
Marital status
| | |
<0.001
| |
<0.001
| |
<0.001
|
|
Single
|
195 (49.8%)
|
14(7.2%)
| |
160 (82%)
| |
11(5.7%)
| |
|
Married
|
166 (42.4%)
|
40(24%)
| |
99 (59.7%)
| |
18 (10.6%)
| |
|
Other
|
30 (7.6%)
|
3 (10%)
| |
23 (76.7%)
| |
2 (6.7%)
| |
|
Risk Factor
| | |
<0.001
| |
<0.001
| |
<0.001
|
|
IDU
|
202 (51.6%)
|
12 (5.9%)
| |
172 (85.2%)
| |
8 (3.1%)
| |
|
Sexual
|
11 (2.8%)
|
4 (3.4%)
| |
3 (27.3%)
| |
1 (9%)
| |
|
Transfusion
|
12 (3%)
|
0 (0%)
| |
12 (100%)
| |
0 (0%)
| |
|
Sex & IDU
|
56 (14.3%)
|
6 (10.7%)
| |
36 (64.3%)
| |
13(23.2%)
| |
|
Pregnant
|
5 (1.2%)
|
2 (40%)
| |
0 (0%)
| |
0 (0%)
| |
|
Other
|
105 (26.8%)
|
33(31.5%)
| |
59 (56.2%)
| |
9 (8.6%)
| |
|
Occupation
| | |
<0.001
| |
<0.001
| |
<0.001
|
|
Unemployed
|
221 (56.5%)
|
16 (7.2%)
| |
174 (78.7%)
| |
15 (6.8%)
| |
|
Self employed
|
63 (16.1%)
|
8 (12.7%)
| |
47 (74.6%)
| |
4 (6.3%)
| |
|
Worker
|
42)10.7%)
|
6 (14.3%)
| |
33 (78.6%)
| |
3 (7.2%)
| |
|
Employee
|
3 (0.7%)
|
1) 33.3%)
| |
2 (66.7%)
| |
0) 0%)
| |
|
housewife
|
32 (8.1%)
|
16 (50%)
| |
8) 25%)
| |
7 (21.9%)
| |
|
Farmer
|
4 (1%)
|
4 (100%)
| |
0 (0%)
| |
0 (0%)
| |
|
Student
|
12 (3%)
|
3 (25%)
| |
9 (75%)
| |
0 (0%)
| |
|
Driver
|
10 (2.5%)
|
2 (20%)
| |
6 (60%)
| |
20 (20%)
| |
|
Other
|
4 (1%)
|
1 (25%)
| |
3 (75%)
| |
0 (0%)
| |
- HBsAg: HBV surface antigen, anti-HCV: antibody against HCV, N: number of patients, p: p-value, IDU: Injection drugs users
